Crucell Teams up with ACE BioSciences and Harvard to Accelerate Bacterial Antibody Program
November 02, 2005 02:12 ET
|
Crucell N.V.
LEIDEN, Netherlands, Nov. 02, 2005 (PRIMEZONE) -- Dutch biotechnology company Crucell N.V. (Euronext:CRXL) (Nasdaq:CRXL) announced today that it has licensed bacterial antigens from ACE BioSciences...